Article

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 Variants

2021-10-30

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> COVID-19 convalescent plasma (CCP) was widely used as passive immunotherapy during the first waves of SARS-CoV-2 infection in the US. However, based on observational studies and randomized controlled trials, beneficial effects of CCP were limited, and its use was virtually discontinued early in 2021, in concurrence with increased vaccination rates and availability of monoclona...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2448c940-336b-58f8-842c-a2d9188369b1
DOI: 10.1101/2021.10.28.21265622

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 VariantsDOI 10.1101/2021.10.28.21265622Read

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationSemantic proximity Read

Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)Semantic proximity Read

Functional Antibodies in COVID-19 Convalescent PlasmaSemantic proximity Read

Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19Semantic proximity Read

A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma TherapySemantic proximity Read

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasmaSemantic proximity Read

High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samplesSemantic proximity Read

Dynamics of SARS-CoV-2-specific antibodies during and after COVID19: Lessons from a biobank in ArgentinaSemantic proximity Read

Profiling B cell immune responses to identify neutralizing antibodies from convalescent COVID-19 patientsSemantic proximity Read

Epitope Diversity and SARS-CoV-2 Variants Neutralizing Capacity of SARS-CoV-2 Hyperimmune Intravenous Immunoglobulins for Treatment of COVID-19Semantic proximity Read

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccinationSemantic proximity Read

Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemicSemantic proximity Read